NYSE ARCA | ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries.
While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MDT | Medtronic PLC | Healthcare | Medical Devices | 3.44% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.37% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 3.34% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.70% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.53% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.52% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 2.50% | ||
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.49% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 2.44% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.44% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 2.32% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.24% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 2.23% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.13% |
| COO | The Cooper Companies Inc. | Healthcare | Medical Instruments & Supplies | 2.10% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 2.07% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 2.05% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.05% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 2.04% |
| LH | Laboratory Corporation of America Holdings | Healthcare | Diagnostics & Research | 1.99% |